Objective-Two were the aims of this study: first, to translate whole-genome expression profiles into computational predictions of functional associations between signaling pathways that regulate aorta homeostasis and the activity of angiotensin II type 1a receptor (At1ar) in either vascular endothelial or smooth muscle cells; and second, to characterize the impact of endothelial cell-or smooth muscle cell-specific At1ar disruption on the development of thoracic aortic aneurysm in fibrillin-1 hypomorphic (Fbn1 mgR/mgR ) mice, a validated animal model of early onset progressively severe Marfan syndrome. Approach and Results-Cdh5-Cre and Sm22-Cre transgenic mice were used to inactivate the At1ar-coding gene (Agt1ar) 
T horacic aortic aneurysms (TAA) are life-threatening pathologies characterized by progressive vessel dilation associated with smooth muscle cell (SMC) dysfunction and maladaptive extracellular matrix remodeling that can ultimately lead to arterial wall dissection and rupture. 1 Angiotensin II (AngII) type 1 receptor (At1r) hyperactivity plays a primary role in promoting arterial disease in mice with either genetic or AngII-induced TAA. 2 Whereas inactivation of Agt1ar, the gene coding for the type 1a receptor (At1ar), in intimal but not medial cells of AngII-infused hypercholesterolemic mice has been shown to attenuate aneurysm pathology, 3 no comparable information is currently available for mouse models of inherited TAA.
Dissecting TAA is the major morbidity/mortality factor in Marfan syndrome (MFS), a relatively common connective tissue disease caused by mutations in the extracellular matrix protein fibrillin-1. 1 Early analyses of MFS mice with nondissecting TAA (Fbn1 C1039G/+ mice) concluded that aneurysm formation is largely accounted for by At1r-induced TGFβ (transforming growth factor-β) hyperactivity. 4 However, subsequent characterization of MFS mice with dissecting TAA (Fbn1 mgR/mgR mice) associated promiscuous At1r and TGFβ signaling with partially overlapping processes of arterial disease. 5 Because both studies used an AngII receptor antagonist, neither of them discriminated between the pathogenic role of the type 1a and 1b receptors. In line with current evidence excluding a major involvement of At1br in aortic aneurysms, 6 here we focused on At1ar activity in distinct compartments of the aortic wall of wild-type and MFS mice. Our genetic, computational, and biochemical findings demonstrate the differential impact of At1ar expressed on either intimal or medial cells on both aorta homeostasis and aneurysmal disease.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results
As we sought to characterize the influence of endothelial cell (EC)-and SMC-specific AT1ar on TAA development in MFS mice, we first generated computational predictions of signaling pathways in the wild-type aorta that are influenced by Objective-Two were the aims of this study: first, to translate whole-genome expression profiles into computational predictions of functional associations between signaling pathways that regulate aorta homeostasis and the activity of angiotensin II type 1a receptor (At1ar) in either vascular endothelial or smooth muscle cells; and second, to characterize the impact of endothelial cell-or smooth muscle cell-specific At1ar disruption on the development of thoracic aortic aneurysm in Sm22−/− mice exhibited a shortened life span and/or overt vascular defects (data not shown), their aorta cells displayed distinct profiles of differentially expressed genes, in terms of both number and identity of up-and downregulated genes ( Figure 1A ; Table I in the online-only Data Supplement). This finding strongly suggested that physiological At1ar activity in the 2 aortic compartments influences distinct signaling pathways and subcellular processes across the entire vessel wall. Indeed, ingenuity pathway analysis of the differentially expressed genes predicted that different top 1% pathways were affected by At1ar loss in the intimal versus medial compartments. Specifically, ingenuity pathway analysis inferred inhibition of TGFβ signaling and stimulation of interferon signaling in Agt1ar
Cdh5−/− aortas and downregulation of ILK (integrin-linked kinase) and RhoA (Ras homolog gene family, member A) activity in Agt1ar Sm22−/− aortas ( Figure 1B ). Having predicted cell type-specific contributions of At1ar activity to aorta homeostasis, we next assessed the influence 
;Agt1ar
Sm22−/− mice were performed at 3 months of age to evaluate potential modifications in median survival and TAA pathology and at 2 months of age to evaluate overactivation (phosphorylation) of aneurysm-related Erk1/2 and Smad2 proteins. 5 RNA transcript analyses showed significant Agt1ar inactivation in ECs and SMCs of Fbn1 mgR/mgR aortas ( Figure I in the online-only Data Supplement). Necroscopic analyses revealed that all but one mouse had died from ruptured TAA (Figure 2A) . Improved median survival of mice with EC-specific Agt1ar ablation was associated with mitigated aneurysm growth and media degeneration ( 
Discussion
Creation of Agt1ar conditional null mice has recently provided the experimental means to determine the cellular loci of the receptor that mediate AngII-induced aortic pathology in mice. 3 Cell type-specific loss-of-function experiments in AngII-infused wild-type mice have implicated adventitial 
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(fibroblast) At1ar in stimulating medial hyperplasia, 7 whereas loss of receptor activity in the endothelium of AngII-infused Ldlr −/− mice has inferred a role in intima area expansion, medial thickening, and elastin fragmentation. 3 In the present study, the Agt1ar conditional null mice were initially used to determine whether At1ar expression in intimal and medial cells influences distinct intracellular signals in the mouse aorta.
Computational analysis of the transcriptome of Agt1ar
Cdh5−/− aortas identified stimulation of interferon signaling and inhibition of TGFβ activity as the top-ranking pathways predicted to be influenced across the aortic wall by the loss of the receptor in the intimal compartment. INFγ/JNK/IRF (interferon-γ/c-Jun N-terminal kinase/interferon regulatory factors) signaling has been reported to mediate stretch-induced vascular SMC apoptosis, 8 whereas basal TGFβ activity has been shown to support aortic wall homeostasis. 9 We, therefore, argue that At1ar activity in the endothelium regulates both survival and extracellular matrix remodeling activities of the underlying SMCs. We also infer a probable role of At1ar expressed on medial SMCs in regulating cell adhesion and contractility based on the computational prediction that the top modified pathways in Agt1ar Sm22−/− aortas are associated with integrin signaling and cytoskeleton dynamics. Irrespective of the identity of these functional connections, our analyses clearly attribute distinct physiological roles to At1ar activity in aortic ECs and SMCs, in addition to predicting receptor-stimulated communication between the inner and medial compartments of the vessel wall.
Similar to AngII-induced aneurysmal disease in Ldlr −/− mice with cell type-specific Agt1ar dysruption, 3 lossof-function experiments in MFS mice demonstrated that fibrillin-1 deficiency promotes TAA development in part by overstimulating At1ar expressed on ECs. This G protein-coupled receptor can also signal independently of AngII or G protein activation through conformation-specific associations of the receptor with β-arrestin proteins. 10 By analogy with AngIIindependent overstimulation of At1ar/β-arrestin-2/Erk1/2 mechanosignaling in the myocardium of Fbn1 mgR/mgR mice, 11 we speculate that At1ar expressed on intimal ECs may function as a mechanosensor that communicates hemodynamic stress stimuli to the underlying intramural cells. Consistent with the predictions of our computational analyses, we further speculate that probable dysregulated targets of improper At1ar signaling in the intima of MFS mice may include survival and extracellular matrix remodeling activities of medial SMCs. Relative levels of p-Erk1/2 and p-Smad2 in the aortas of MFS mice have traditionally been viewed as surrogate readouts of aneurysmal disease. 4, 5 Indeed, it has been argued that TAA development in Fbn1 C1039G/+ mice is largely driven by At1r-stimulated noncanonical (Erk-mediated) TGFβ signaling. 12 In contrast to this early postulate, normalization of p-Erk1/2 and p-Smad2 levels in Fbn1 mgR/mgR aortas deficient for At1ar expression in the medial compartment was not accompanied by mitigation of TAA pathology. Furthermore, amelioration of TAA pathology in Fbn1 mgR/mgR mice with EC-specific loss of At1ar activity was associated with significant reduction of p-Erk1/2 but not p-Smad2. These findings reiterate the notion that TGFβ hyperactivity is not a primary trigger of TAA in MFS, 5, 13 in addition to suggesting that endothelial At1ar dysfunction promotes aneurysmal disease in MFS by perturbing several other signaling pathways. Ongoing computational analyses of disease-centered molecular networks constructed from the transcriptomes of aortic cells under different genetic constrains are testing the validity of this hypothesis.
